☆ 4.2 Article

Effect of the Duration of NSAID Use on COVID-19

MEDICINA-LITHUANIA (2022)

Related references

Note: Only part of the references are listed.

Article Virology

NSAID use and clinical outcomes in COVID-19 patients: a 38-center retrospective cohort study

Justin T. Reese et al.

Summary: This study found that the use of non-steroidal anti-inflammatory drugs (NSAIDs) is not associated with increased severity or other adverse outcomes in COVID-19 inpatients. The results confirm and extend the findings of previous observational studies and provide evidence against the initial concerns raised about the use of NSAIDs in COVID-19 patients.

VIROLOGY JOURNAL (2022)

Add to Collection

Article Immunology

Association Between Nonsteroidal Antiinflammatory Drug Use and Adverse Clinical Outcomes Among Adults Hospitalized With Coronavirus 2019 in South Korea: A Nationwide Study

Han Eol Jeong et al.

Summary: Based on the cohort study using South Korea's healthcare database, it was found that using nonsteroidal antiinflammatory drugs (NSAIDs) in COVID-19 patients may increase the risk of adverse outcomes. Therefore, caution is advised when using NSAIDs in COVID-19 patients until further confirmatory studies are conducted to weigh the risks and benefits.

CLINICAL INFECTIOUS DISEASES (2021)

Add to Collection

Editorial Material Rheumatology

Going viral: misinformation in the time of COVID-19

[Anonymous]

LANCET RHEUMATOLOGY (2021)

Add to Collection

Article Rheumatology

Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts

Angel Y. S. Wong et al.

Summary: Two cohort studies were conducted to assess the association between routinely prescribed NSAIDs and COVID-19 related deaths, finding no evidence of a harmful effect. Therefore, the risks of COVID-19 do not need to influence decisions about the routine therapeutic use of NSAIDs.

ANNALS OF THE RHEUMATIC DISEASES (2021)

Add to Collection

Article Rheumatology

Nonsteroidal Antiinflammatory Drugs and Susceptibility to COVID-19

Joht Singh Chandan et al.

Summary: The study found that there was no increased risk of suspected or confirmed COVID-19 or mortality among osteoarthritis patients in primary care settings who were prescribed NSAIDs compared to those who received other common analgesics. These results suggest that NSAIDs can be safely prescribed during the ongoing pandemic in the absence of acute illness.

ARTHRITIS & RHEUMATOLOGY (2021)

Add to Collection

Review Public, Environmental & Occupational Health

NSAIDs and COVID-19: A Systematic Review and Meta-analysis

Nicholas Moore et al.

Summary: Observational data indicates that the theoretical risks of NSAIDs or ibuprofen in SARS-CoV-2 infection are not confirmed, as exposure to NSAIDs or ibuprofen did not increase the risk of hospital admission, death, or severe outcomes in SARS-CoV-2-positive patients.

DRUG SAFETY (2021)

Add to Collection

Article Medicine, General & Internal

Aspirin Is Related to Worse Clinical Outcomes of COVID-19

Isaac Kim et al.

Summary: The study found that aspirin use was associated with adverse effects in COVID-19 patients, with aspirin use before COVID-19 related to increased death rates and aspirin use after COVID-19 related to a higher risk of requiring conventional oxygen therapy. Further studies on the mechanisms are needed.

MEDICINA-LITHUANIA (2021)

Add to Collection

Article Medicine, General & Internal

A Novel Coronavirus from Patients with Pneumonia in China, 2019

Na Zhu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Immunology

Association of Renin-angiotensin-aldosterone System Inhibitors With Coronavirus Disease 2019 (COVID-19)-Related Outcomes in Korea: A Nationwide Population-based Cohort Study

Sun-Young Jung et al.

CLINICAL INFECTIOUS DISEASES (2020)

Add to Collection

Review Pharmacology & Pharmacy

Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection

Joelle Micallef et al.

THERAPIE (2020)

Add to Collection

Letter Critical Care Medicine

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

Lei Fang et al.

LANCET RESPIRATORY MEDICINE (2020)

Add to Collection

Editorial Material Public, Environmental & Occupational Health

Does Ibuprofen Worsen COVID-19?

Nicholas Moore et al.

DRUG SAFETY (2020)

Add to Collection

Review Pharmacology & Pharmacy

Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective

Samik Bindu et al.

BIOCHEMICAL PHARMACOLOGY (2020)

Add to Collection

Article Medicine, General & Internal

Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study

Lars Christian Lund et al.

PLOS MEDICINE (2020)

Add to Collection

Review Clinical Neurology

Nonsteroidal anti-inflammatory drugs in chronic pain: implications of new data for clinical practice

Kok Yuen Ho et al.

JOURNAL OF PAIN RESEARCH (2018)

Add to Collection

Review Pharmacology & Pharmacy

Molecular basis for nonspecificity of nonsteroidal anti-inflammatory drugs (NSAIDs)

Avaneesh K. Dwivedi et al.

DRUG DISCOVERY TODAY (2015)

Add to Collection

© Peeref 2019-2024. All rights reserved.